Insider trading

Period: 12 months Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,881 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,881 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,881 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,881 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,881 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,881 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,881 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Sep 2026
Omer Gal CLO
Sold at will
$67.75K 1,500 at 45.17
7.5%
Not planned
16 Sep 2026
Mazanderani Ali Executive Chairman
Bought
$65.01K 14,774 at 4.40
0.6%
16 Sep 2026
Mensinger Mike Chief Product Officer
Sold on a plan
$58.30K 2,650 at 22.00
1.5%
Planned (10b5-1)
16 Sep 2026
Lin Lauren CLO, CCO and Secretary
Sold at will
$50.90K 4,995 at 10.19
2.8%
Not planned
16 Sep 2026
Garthwaite Michael P. VP (Pres., Products Pipelines)
Sold on a plan
$47.74K 1,550 at 30.80
3.1%
Planned (10b5-1)
16 Sep 2026
Mohan Ajit Chief Business Officer
Sold at will
$39.58K 6,797 at 5.82
0.1%
Not planned
16 Sep 2026
Macwan Sanjay Chief Information Officer
Sold at will
$38.49K 6,936 at 5.55
1.3%
Not planned
16 Sep 2026
KOUNINIS EFSTATHIOS A SVP, Chief Accounting Officer
Sold at will
$36.68K 982 at 37.35
49.3%
Not planned
16 Sep 2026
Vieira Roberto Wandenkolk President, Oncology
Sold on a plan
$29.84K 296 at 100.82
7.0%
Planned (10b5-1)
16 Sep 2026
AULT MILTON C III Executive Chairman · indirect
Bought
$22.90K 125,000 at 0.18
4.5%
16 Sep 2026
Bizily Scott Chief Legal Officer
Sold on a plan
$22.32K 1,635 at 13.65
15.9%
Planned (10b5-1)
16 Sep 2026
Villani Fiorenzo See Remarks
Bought
$17.27K 4,265 at 4.05
12.3%
16 Sep 2026
CORTEGOSO PABLO Chief Technical Officer
Sold on a plan
$16.29K 123,614 at 0.13
21.1%
Planned (10b5-1)
16 Sep 2026
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER
Sold on a plan
$14.71K 3,170 at 4.64
1.1%
Planned (10b5-1)
16 Sep 2026
McNeill Jonathan President and COO
Sold on a plan
$13.08K 731 at 17.90
0.5%
Planned (10b5-1)
16 Sep 2026
RAIGUEL DARREN S CHIEF OPERATING OFFICER · indirect
Sold on a plan 2×
$12.98K 139 at 93.38
0.2%
Planned (10b5-1)
16 Sep 2026
Pinkas Jan Chief Scientific Officer
Sold on a plan
$11.78K 658 at 17.90
3.0%
Planned (10b5-1)
16 Sep 2026
Im Ellie Eunkyung Chief Medical Officer
Sold on a plan
$11.15K 623 at 17.90
2.8%
Planned (10b5-1)
16 Sep 2026
Sold on a plan
$11.10K 620 at 17.90
3.2%
Planned (10b5-1)
16 Sep 2026
Gomes Andre Spolidoro Ferreira Chief Strategy Officer · indirect
Sold on a plan
$11.04K 3,000 at 3.68
9.0%
Planned (10b5-1)
16 Sep 2026
Gomes Andre Spolidoro Ferreira Chief Strategy Officer
Sold on a plan
$11.04K 3,000 at 3.68
1.0%
Planned (10b5-1)
16 Sep 2026
Azaria Eynav See Remarks
Sold at will
$10.09K 7,116 at 1.42
0.4%
Not planned
16 Sep 2026
Shams Sammaad Chief Accounting Officer
Sold on a plan
$6.36K 430 at 14.79
0.6%
Planned (10b5-1)
16 Sep 2026
Yonehiro Grant Chief Operating Officer
Sold at will
$5.35K 1,417 at 3.77
4.7%
Not planned
16 Sep 2026
Deykin Aaron Chief Medical Officer
Sold at will
$4.91K 895 at 5.49
2.7%
Not planned
16 Sep 2026
Lynch Ryan See Remarks
Sold on a plan
$4.30K 240 at 17.90
1.7%
Planned (10b5-1)
16 Sep 2026
Houghton Adam Chief Business Officer
Sold at will
$3.84K 700 at 5.49
3.0%
Not planned
16 Sep 2026
AULT MILTON C III Executive Chairman
Bought
$3.54K 19,500 at 0.18
2.4%
16 Sep 2026
Nemec Sarah Senior VP, Finance and PAO
Sold at will
$3.18K 843 at 3.77
3.4%
Not planned
16 Sep 2026
Ambrose Allison General Counsel
Sold at will
$2.66K 485 at 5.49
3.0%
Not planned
16 Sep 2026
Robertson John Adam Executive Chairperson
Bought
$2.29K 70 at 32.69
0.2%
16 Sep 2026
Bridgford Allan Jr. Consultant
Bought
$1.92K 326 at 5.90
0.7%
16 Sep 2026
Celano Chris Edward Chief Operating Officer
Sold at will
$103.02 739 at 0.14
0.7%
Not planned
15 Sep 2026
Teh Ban Seng EVP & Chief Commercial Officer
Sold on a plan 24×
$41.24M 52,730 at 782.08
90.1%
Sold half or more
15 Sep 2026
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 13×
$17.36M 50,000 at 347.19
2.3%
Planned (10b5-1)
15 Sep 2026
Cox Christopher K Chief Product Officer · indirect
Sold on a plan
$13.50M 20,000 at 675.23
8.2%
Planned (10b5-1)
15 Sep 2026
Sold at will
$11.94M 15,466 at 772.15
33.2%
Not planned
15 Sep 2026
Norrod Forrest Eugene EVP & GM DSG
Sold on a plan 9×
$8.68M 17,261 at 503.05
4.5%
Planned (10b5-1)
15 Sep 2026
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER
Sold on a plan 4×
$6.36M 102,190 at 62.26
46.6%
Planned (10b5-1)
15 Sep 2026
ROTE WILLIAM E. Chief Research Officer
Sold on a plan 4×
$5.99M 96,198 at 62.25
49.5%
Planned (10b5-1)
15 Sep 2026
Hoge Stephen President
Sold on a plan
$5.88M 40,281 at 146.07
2.5%
Planned (10b5-1)
15 Sep 2026
Reiss Joel Co-Chief Operating Officer
Sold on a plan 27×
$4.27M 3,900 at 1,094.58
52.0%
Sold half or more
15 Sep 2026
Johnson Samuel J President
Sold at will 3×
$3.64M 70,303 at 51.79
65.6%
Sold half or more
15 Sep 2026
FRANKEL ADAM B General Counsel
Sold on a plan 2×
$3.40M 102,002 at 33.31
21.8%
Planned (10b5-1)
15 Sep 2026
Maurer Mark Lowry Chief Risk Officer
Sold on a plan
$3.39M 50,528 at 67.02
19.9%
Planned (10b5-1)
15 Sep 2026
Chen Wen-Chang (Victor) Chief Strategy Officer
Sold at will
$3.12M 117,461 at 26.60
21.3%
Not planned
15 Sep 2026
Chen Jingye CPO, Shopee · indirect
Sold on a plan 4×
$3.11M 30,000 at 103.83
16.7%
Planned (10b5-1)
15 Sep 2026
CAGNONI PABLO J President, Global Head of R&D
Sold on a plan 2×
$2.80M 23,218 at 120.49
11.2%
Planned (10b5-1)
15 Sep 2026
Inrig Jula EVP, Head of R&D & CMO
Sold on a plan 4×
$2.79M 44,674 at 62.34
30.8%
Planned (10b5-1)
15 Sep 2026
REED ELIZABETH E Chief Legal Officer and GC
Sold on a plan 4×
$2.34M 37,500 at 62.34
26.2%
Planned (10b5-1)
Showing 1,001–1,050 of 22,881. ← Newer Page 21 of 458 Older →